-transparent.png){kind=logo}
A cell line derived from a well-differentiated human transitional cell carcinoma of the urinary bladder, designated TSGH-8301, was established in vitro. The cultured epithelioid cells exhibited monolayer growth and loss of contact inhibition. The tumorigenicity of TSGH-8301 had been shown by growth in soft agar and tumor induction in athymic nude mice. A reverse ratio of lactate dehydrogenase (LHD) isoenzyme in the cell line and nude mouse-grown tumors was seen predominantly with LDH-V. Chromosomal analysis revealed a heterodiploid stem line with a modal number of 50. Sera of urinary bladder cancer patients reacted with membrane antigens of the TSGH-8301 cells, suggesting the existence of tumor-associated antigens in the cells. In vitro chemosensitivity tests of these cells may provide data valuable in the selection of proper anticancer drugs for the TSGH-8301 donor patient.
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
April 1988,
Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
November 1978,
Investigative urology,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
July 1988,
Journal of surgical oncology,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
September 2012,
International journal of oncology,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
March 1988,
Human cell,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
April 2019,
Anticancer research,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
January 1995,
Urological research,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
January 2000,
Anticancer research,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
November 2010,
International journal of oncology,
M Y Yeh, and
D S Yü, and
S C Chen, and
M S Lin, and
S Y Chang, and
C P Ma, and
S H Han
July 2017,
Oncology letters,
